GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Rainmed Medical Ltd (HKSE:02297) » Definitions » Inventories, Inventories Adjustments

Rainmed Medical (HKSE:02297) Inventories, Inventories Adjustments : HK$0.00 Mil (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Rainmed Medical Inventories, Inventories Adjustments?

Rainmed Medical's Inventories, Inventories Adjustments for the quarter that ended in Dec. 2024 was HK$0.00 Mil.


Rainmed Medical Inventories, Inventories Adjustments Historical Data

The historical data trend for Rainmed Medical's Inventories, Inventories Adjustments can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rainmed Medical Inventories, Inventories Adjustments Chart

Rainmed Medical Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Inventories, Inventories Adjustments
- - - - -

Rainmed Medical Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Inventories, Inventories Adjustments Get a 7-Day Free Trial Premium Member Only - - - - -

Rainmed Medical Inventories, Inventories Adjustments Calculation

Inventories, Inventories Adjustments represents certain charges made in the current period in inventory resulting from breakage, spoilage, employee theft and shoplifting, etc.


Rainmed Medical Business Description

Traded in Other Exchanges
N/A
Address
No. 99, Jinji Lake Avenue, Building 31, Northeast District, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN, 215000
Rainmed Medical Ltd is focused on the design, development, and commercialization of coronary angiography-derived fractional flow reserve systems and coronary angiography-derived index of microcirculatory resistance systems. The company's core products, the caFFR system and the caIMR system are medical devices used to evaluate the severity of myocardial ischemia arising from coronary artery stenosis and microvascular dysfunction, which are the underlying causes of coronary artery diseases (CAD). It operates in China and Other countries.
Executives
Zhu Zeke 2201 Interest of corporation controlled by you
Apsara Technology Limited 2101 Beneficial owner
Huo Yunfei 2101 Beneficial owner
Huo Yunlong
Zhou Bin
Zhong Guo Ping An Bao Xian Ji Tuan Gu Fen You Xian Gong Si
Shang Hai Jing Wu Tou Zi Zhong Xin You Xian He Huo
Xin Yu Tong Chuang Jing Xuan Tou Zi Guan Li You Xian Gong Si
Shang Hai Jing Mai Run Qi Ye Guan Li Zhong Xin You Xian He Huo
Gong Qing Cheng Jing Cheng Yu Tou Zi Guan Li He Huo Qi Ye You Xian He Huo
Gong Qing Cheng Jing Lin Jing Jia Tou Zi Guan Li He Huo Qi Ye You Xian He Huo
Jing Lin Zi Ben Guan Li You Xian Gong Si
Shen Zhen Jing Lin Jing Ying Gu Quan Tou Zi Ji Jin He Huo Qi Ye You Xian He Huo
Shen Zhen Jing Hui Gu Quan Tou Zi Guan Li He Huo Qi Ye You Xian He Huo
Xi Zang Jing Jia Qi Ye Guan Li You Xian Ze Ren Gong Si

Rainmed Medical Headlines

No Headlines